Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication.
Caifeng ShiYemeng WanAiqin HeXiaomei WuXinjia ShenXueting ZhuJunwei YangYang ZhouPublished in: Acta diabetologica (2023)
In T2D, several associated urinary metabolites were identified to improve the prediction of DKD. Whether interventions aimed at reducing CMI also reduce the risk of DKD especially in patients with high IL-18 needs further investigations.